Text Size

A A A

Search


 

 

smile man with mustache

Atrial Fibrillation: Guidance in Educating Patients to Prevent Stroke

A Grand Rounds Program

Find and register for the program
at your hospital.

View locations

To learn more about holding a grand rounds
activity at your hospital, please contact
Valerie Siebert-Thomas
at vsiebert-thomas@stroke.org
or call 303-754-0926.

Program Overview

Atrial fibrillation (Afib) affects more than two million people in the US and is a serious risk factor for stroke. Despite evidence-based guidelines for managing Afib, and estimates that two-thirds of Afib-related strokes can be avoided, serious gaps continue to exist between clinical knowledge and practice, leaving patients at risk for disabling strokes. Clinicians and patients tend to underestimate stroke risk associated with Afib, or they are unaware that strokes associated with Afib have significantly higher morbidity and mortality compared with strokes not associated with Afib. Other outcomes associated with stroke in patients with Afib also include stroke recurrence and greater functional impairment and dependency. Although existing guidelines define effective therapeutic strategies for managing Afib to reduce stroke risk, these strategies are frequently underused or inappropriately understood. Both physician and patient knowledge and attitudes play an important role in the success of current strategies to manage Afib to prevent stroke.

Purpose Statement

To educate learners and provide them with tools and resources to use with Afib patients in an effort to increase their patients’ awareness and understanding of Afib, its connection to stroke and the importance of proper management.

Proposed Agenda

  • Prevalence of Afib and risk for stroke
  • Signs and symptoms of Afib
  • Current guidelines for treatment/management
  • Effective communication with patients
    • To ensure health literacy
    • To ensure adherence
    • To ensure follow-up visits

Goals and Learning Objectives

The Atrial Fibrillation: Guidance in Educating Patients to Prevent Stroke grand rounds activity intends to:

  • Raise awareness of the connection of atrial fibrillation (Afib) and stroke.
  • Provide education regarding Afib and emphasizing the importance of appropriate Afib management to reduce the chance of a stroke.
  • Aid health care providers/educators when they talk to their Afib patient about stroke risk.
  • Provide Afib and stroke resources for the providers/educators to deliver to the Afib patients and their caregivers and family members.
  • Provide information and tools to Afib patients, caregivers and family members to aid in engaging their health care providers in discussion of their Afib management and stroke prevention.
  • Assure continuity of care in Afib patients at risk for stroke.

Target Audience

The target audience for the Atrial Fibrillation: Guidance in Educating Patients to Prevent Stroke grand rounds activity includes:

  • Primary Care Providers – physicians, physician assistants, nurse practitioners, nurses and nurse educators
  • Afib patients, caregivers and family members

Physician Credit

Continuing medical education will not be offered for this activity.  A certificate of attendance will be available upon request.

Nursing Credit

Continuing NURSING education will not be offered for this activity.  A certificate of attendance will be available upon request.

Participation

All participants must complete the post-test and evaluation in order to receive proper credit for attending. There are no fees for participating in and receiving credit for this activity.

Post-Test

Post-test questions have been crafted to assess clinician knowledge. Please complete them and return them to the registration area as you depart today’s program.

Evaluation Form

In addition to the post-assessment, each participant should have received an evaluation. Participants should complete the evaluation/certificate request form at the conclusion of this activity. Please assist National Stroke Association to assess the effectiveness of this program by taking a few minutes to complete the evaluation form.

Certificates of Attendance

Certificates of attendance will be available upon request. Participants must complete the post-test and evaluation in order to receive a certificate. Questions regarding this activity can be directed to vsiebert-thomas@stroke.org.

Authoring Faculty

Philip B. Gorelick, MD, MPH, FACP
Medical Director, Hauenstein Neuroscience Center      
Advantage Health/Saint Mary’s Health Care
Professor, Department of Translational Science & Molecular Medicine
Michigan State University – College of Human Medicine

Fredric A. Reyelts, MD
Medical Director
Advantage Health/Saint Mary's Medical Group
Associate Clinical Professor of Family Medicine
Michigan State University – College of Human Medicine

Disclosure of Conflict of Interest

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of National Stroke Association and/or Boehringer Ingelheim Pharmaceuticals, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of National Stroke Association and/or Boehringer Ingelheim Pharmaceuticals, Inc. 

Faculty Disclosures

Name of Faculty

Philip B. Gorelick, MD, MPH, FACP

Reported Financial Relationship

PI/Co-PI: Lundbeck; PI (dual): World Federation of Neurology and World Stroke Organization; Webinar presenter: Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc.

Fredric A. Reyelts, MD 

No financial relationship to disclose.

Individual faculty members at each of the host locations will be asked to disclose financial conflicts of interest at the beginning of their presentation.

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Muhammad Umar Farooq, MD, FACP, FAHA - No financial relationship to disclose.
Anna Taylor, National Stroke Association - No financial relationship to disclose.
Michelle Murdock, Consultant - No financial relationship to disclose.


The activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Get Involved

Stroke and You

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org